The prospective observational study is to establish a registry database to evaluate the potential impact of prior treatment with CMX001 on the long-term incidence of specific events, such as outcomes, late CMV and other Double-stranded DNA virus associated events, s well as survival rates in subjects previously enrolled in selected clinical studies of CMX001. Each Registry participant will be followed for a period of approximately 3 years from their enrollment in the Registry.
Study Type
OBSERVATIONAL
Enrollment
550
Time to all-cause mortality
evaluate the potential impact of prior treatment with CMX001 on the long-term incidence of specific events, such as the development of new malignancies and late cytomegalovirus (CMV)-associated events, as well as survival rates in subjects previously enrolled in selected clinical studies of CMX001
Time frame: 10 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
University of California San Diego
La Jolla, California, United States
St. Vincent Medical Center
Los Angeles, California, United States
Children's Hospital of LA
Los Angeles, California, United States
UCLA Medical Center
Los Angeles, California, United States
Stanford University
Palo Alto, California, United States
Childrens Hospital of Colorado
Aurora, Colorado, United States
University of Colorado Denver
Aurora, Colorado, United States
University of Colorado Hospital/Health Science Center
Aurora, Colorado, United States
Yale University
New Haven, Connecticut, United States
Children's National Medical Center
Washington D.C., District of Columbia, United States
...and 41 more locations